Axonics (NSDQ:AXNX) posted first-quarter results yesterday that beat the revenue consensus on Wall Street but missed on earnings projections. The Irvine, Calif.-based company reported losses of -$22.5 million, or -57¢ per share, on sales of $34.4 million for the three months ended March 31, for a sales growth of 30.72% compared with Q1 2020. Earnings per […]
Wall Street Beat
Cardiovascular Systems sinks on missed Q3 earnings projections
Cardiovascular Systems (NSDQ:CSII) posted third-quarter results yesterday that beat the revenue consensus on Wall Street but missed on earnings projections. The St. Paul, Minn.-based company reported losses of -$6 million, or -15¢ per share, on sales of $63.27 million for the three months ended March 31, for a sales growth of 3.43% compared with Q1 […]
ICU Medical reports 41% profit increase in Q1
ICU Medical (NSDQ:ICUI) posted first-quarter results yesterday that beat the overall consensus on Wall Street. The San Clemente, Calif.-based company reported profits of $23.7 million, or $1.09 per share, on sales of $318 million for the three months ended March 31, for a bottom-line gain of 41% on sales losses of -3.21% compared with Q1 2020. Adjusted […]
iRhythm Technologies ticks up before hours on mixed-bag Q1 results
iRhythm Technologies (NASDAQ: IRTC) posted first-quarter results yesterday that missed the earnings consensus on Wall Street but beat the revenue projections. The San Francisco-based company reported losses of -$27.8 million, or -95¢ per share, on sales of $74.3 million for the three months ended March 31, for a sales growth of 16.96% compared with Q1 2020. […]
Alphatec sales up 46% in Q1 results
Alphatec (Nasdaq: ATEC) posted first-quarter results yesterday that missed the earnings consensus on Wall Street and matched on revenue estimates. The Carlsbad, Calif.-based company reported losses of -$22.9 million, or -26¢ per share, on sales of $44.12 million for the three months ended March 31, for a sales growth of 46.51% compared with Q1 2020. Earnings […]
Avanos Medical beats The Street in Q1 results
Avanos Medical (NYSE:AVNS) posted first-quarter results today that beat the overall consensus on Wall Street. The Alpharetta, Ga.-based company reported losses of -$7.6 million, or -16¢ per share, on sales of $180.7 million for the three months ended March 31, for a sales growth of 0.17% compared with Q1 2020. Adjusted to exclude one-time items, earnings […]
Moderna sales increase 242 times in Q1, says COVID-19 vaccine 96% effective in teens
Moderna (Nasdaq:MRNA) posted first-quarter results today that beat the earnings consensus on Wall Street and missed on revenue estimates. The company reported profits of $1.2 billion, or $2.84 per share, on sales of $1.9 billion for the three months ended March 31, for a sales growth of 24112% compared with Q1 2020. Earnings per share […]
Ocular Therapeutix misses The Street on bottom-line leap
Ocular Therapeutix (NSDQ:OCUL) reported first-quarter results that missed the consensus forecast on Wall Street. The Bedford, Mass.–based eye disease therapeutic developer posted profits of $3.12 million, or $0.04 per share, on sales of $7.34 million for the three months ended March 31, 2021, for a bottom-line leap of 114% on sales growth of 181% compared […]
Cardinal Health stock down 8% on Q3 earnings miss
Cardinal Health (NYSE:CAH) stock is down today after the company’s third-quarter earnings missed the Wall Street consensus forecast. The Dublin, Ohio–based medical device manufacturer and life science products distributor reported profits of $119 million, or 40¢ per share, off sales of $39.275 billion for the quarter ended March 31, 2021, with earnings down two-thirds off […]
BD to spin off its diabetes business, Q2 earnings beat The Street
BD (NYSE: BDX) announced today that it will spin off its Diabetes Care business as an independent, publicly traded company during the first half of 2022. The Diabetes Care business saw $1.1 billion in sales during BD’s fiscal year ended Sept. 30, 2020, nearly half outside the U.S. The business manufactures roughly 8 billion injection […]
Invacare stock down on mixed-bag Q1 results
Invacare (NYSE:IVC) posted first-quarter results that missed the earnings consensus on Wall Street and matched on revenue estimates. The Elyria, Ohio-based non-acute medical equipment maker yesterday reported losses of –$14.04 million, or –41¢ per share, on sales of $196.2 million for the three months ended March 31, for a sales loss of –10.16% compared with […]
